Navigation Links
Moderate Aerobics May Ease Insomnia Symptoms
Date:6/12/2008

Brazilian study finds 36% reduction in time awake and a drop in anxiety levels

THURSDAY, June 12 (HealthDay News) -- A session of moderate aerobic exercise can help reduce anxiety and improve the quality of sleep for insomnia patients, according to a Brazilian study. Heavy aerobic or moderate strength exercises don't have the same effect.

Researchers at the Federal University of Sao Paulo divided 28 women and eight men with primary chronic insomnia into three exercise groups -- moderate aerobic, heavy aerobic, and moderate strength -- and one control group.

After the exercise session, those who did moderate aerobic exercise showed reductions in sleep onset latency (54 percent) and wake time (36 percent) and increases in total sleep time (21 percent) and sleep efficiency (18 percent). They also showed a 7 percent decrease in anxiety.

"These findings indicate that there is a way to diminish the symptoms of insomnia without using medication," study author Giselle S. Passos said in a prepared statement.

"This is the first study to look at the importance of using physical exercise to treat insomnia and may contribute to increased quality of life in people with one of the most important kind of sleep disorders around the world," Passos said.

The findings were presented Wednesday at the annual meeting of the Associated Professional Sleep Societies, in Baltimore.

More information

The American Academy of Family Physicians has more about insomnia.



-- Robert Preidt



SOURCE: American Academy of Sleep Medicine, news release, June 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
2. Moderate Exercise Cuts Risk of Metabolic Syndrome
3. Gene variant linked to moderated symptoms of beta-thalassemia
4. Moderate Aerobic Fitness Levels May Cut Stroke Risk
5. A Drug With Efficacy Superior to That of Memantine Would Earn up to a 50% Patient Share in the Moderate-to-Severe Alzheimers Disease Drug Market
6. Moderate alcohol consumption in middle age can lower cardiac risk
7. Ad in USA TODAY Touts Benefits of Moderate UV Exposure
8. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
9. Drug Works Well for Moderate-to-Severe Psoriasis
10. IF You Had Survived a Brutal Rape at Gunpoint, Would You Teach Aerobics to Convicted Felons?
11. Aerobics Celebrates 40th Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/29/2017)... , ... March 29, 2017 , ... VisualSP has helped ... Until recently, the only option for on-premises installation of its Help System for SharePoint ... to install the system into the entire tenant. , The company recently released ...
(Date:3/28/2017)... ... 28, 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes ... Risk Test to find out if they are at risk for developing Type 2 ... the evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies announced ... address the resolution to globally reduce the harmful use of alcohol set forth ... and TTB approved ingredients that when infused into alcohol, renders the alcohol liver ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global energy-based aesthetic devices market to grow at ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:3/29/2017)... , March 29, 2017  Novartis announced ... (FDA) has accepted the company,s Biologics License Application ... (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell ... and young adult patients with B-cell acute lymphoblastic ... by Novartis for a CAR-T. The priority review ...
(Date:3/29/2017)...  The Global Health Innovative Technology Fund (GHIT ... battle infectious diseases around the globe, today announced ... help deliver a range of new innovative therapies ... This latest round of targeted support includes ... a pediatric formulation of a drug considered the ...
Breaking Medicine Technology: